Lucas Ward
Stock Analyst at Ascendiant Capital
(0.81)
# 4,031
Out of 5,122 analysts
26
Total ratings
34.62%
Success rate
-28.88%
Average return
Main Sectors:
Stocks Rated by Lucas Ward
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HSCS HeartSciences | Maintains: Buy | $9 → $9.2 | $3.20 | +187.50% | 4 | Dec 22, 2025 | |
| VVOS Vivos Therapeutics | Maintains: Buy | $6.5 → $5.5 | $1.62 | +239.51% | 5 | Dec 3, 2025 | |
| SXTP 60 Degrees Pharmaceuticals | Maintains: Buy | $12 → $11 | $3.64 | +207.69% | 4 | Nov 28, 2025 | |
| ACON Aclarion | Maintains: Buy | $22 → $23 | $2.88 | +698.61% | 5 | Nov 20, 2025 | |
| LIQT LiqTech International | Maintains: Buy | $4 → $4.2 | $1.72 | +144.19% | 6 | Nov 20, 2025 | |
| VMAR Vision Marine Technologies | Maintains: Buy | $135,000 → $108,000 | $3.13 | +3,450,379.23% | 2 | Jul 29, 2024 |
HeartSciences
Dec 22, 2025
Maintains: Buy
Price Target: $9 → $9.2
Current: $3.20
Upside: +187.50%
Vivos Therapeutics
Dec 3, 2025
Maintains: Buy
Price Target: $6.5 → $5.5
Current: $1.62
Upside: +239.51%
60 Degrees Pharmaceuticals
Nov 28, 2025
Maintains: Buy
Price Target: $12 → $11
Current: $3.64
Upside: +207.69%
Aclarion
Nov 20, 2025
Maintains: Buy
Price Target: $22 → $23
Current: $2.88
Upside: +698.61%
LiqTech International
Nov 20, 2025
Maintains: Buy
Price Target: $4 → $4.2
Current: $1.72
Upside: +144.19%
Vision Marine Technologies
Jul 29, 2024
Maintains: Buy
Price Target: $135,000 → $108,000
Current: $3.13
Upside: +3,450,379.23%